STACIE EGAN: Open Payments
NPI 1376062752 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$99,583 in 385 payments from 20 companies in 2025. Trend: 2023 $25,988 · 2024 $36,612 · 2025 $99,583
Speaker / faculty: $66,170Travel & lodging: $22,665Food & beverage: $6,681Consulting: $3,970Education: $97
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 113 | $60,363 |
| ABBVIE INC. | 138 | $34,721 |
| Phathom Pharmaceuticals, Inc. | 8 | $2,610 |
| Aimmune Therapeutics, Inc. | 25 | $277 |
| Ardelyx, Inc. | 14 | $253 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $227 |
| Novo Nordisk Inc | 9 | $219 |
| PFIZER INC. | 27 | $166 |
| Janssen Biotech, Inc. | 7 | $126 |
| Lilly USA, LLC | 4 | $120 |
Products named: REZDIFFRA, SKYRIZI, CREON, RINVOQ, VOQUEZNA, IBSRELA, ENTYVIO, LINZESS.
Industry payments across UT — which companies pay providers there.
